Donald W. Landry, M.D., Ph.D.
Assistant Professor of Medicine
Columbia University College of Physicians & Surgeons
New York, NY
Director, Division of Clinical Pharmacology and
Experimental Therapies, Department of Medicine
Physicians & Surgeons, 10-445
630 West 168th Street
New York, NY 10032
(212) 305-1890
(212) 305-3475
dwl1@columbia.edu
Video of the two questions below.
Full Question and Answer Session (audio): (times are in parentheses*)
1. Even if anti-cocaine catalytic antibodies are successful, wouldn't addicts be able to just change their drug of choice?2. What problems do you think might arise with the use of these antibodies?